文献速递流行病学与生物统计

瑞典人群乳糜泻与死亡风险的关联

Association Between Celiac Disease and Mortality Risk in a Swedish Population.
PubMed 文献 · JAMA · 2020-01-01

中位随访12.5年,乳糜泻患者全因死亡率为9.7/1000人年,对照组为8.6/1000人年(HR 1.21,95%CI 1.17-1.25),死亡风险在各年龄段均升高,18-39岁确诊者HR最高为1.69。

要点

  • 乳糜泻患者全因死亡风险较一般人群升高21%(HR 1.21)。
  • 18-39岁确诊者死亡风险升高最显著(HR 1.69)。
  • 诊断后第一年死亡风险最高(HR 2.34),但10年后仍持续存在。

核心结论

  • 在瑞典1969至2017年人群中,乳糜泻诊断与小幅但统计学显著升高的死亡风险相关。

主要发现

  • 中位随访12.5年,乳糜泻患者全因死亡率为9.7/1000人年,对照组为8.6/1000人年(绝对差1.2/1000人年;HR 1.21,95%CI 1.17-1.25)。
  • 18-39岁确诊者死亡率为1.9/1000人年,对照组为1.1/1000人年(HR 1.69,95%CI 1.47-1.94;与40-59岁和≥60岁比较的异质性P值均<.001)。
  • 心血管病死亡率为3.5 vs 3.4/1000人年(HR 1.08,95%CI 1.02-1.13),癌症为2.7 vs 2.2/1000人年(HR 1.29,95%CI 1.22-1.36),呼吸系统疾病为0.6 vs 0.5/1000人年(HR 1.21,95%CI 1.08-1.37)。
  • 诊断后第一年死亡风险最高(15.3 vs 6.5/1000人年;HR 2.34,95%CI 2.14-2.55),10年后仍持续(10.5 vs 10.1/1000人年;HR 1.15,95%CI 1.10-1.20)。
  • 2010-2017年确诊者死亡风险仍存在(7.5 vs 5.5/1000人年;HR 1.35,95%CI 1.21-1.51)。

临床怎么用

  • 乳糜泻患者应被视为死亡风险轻度升高的人群,尤其在确诊后第一年需加强监测。
  • 年轻成人(18-39岁)确诊乳糜泻时死亡风险相对升高更明显,提示该年龄段也需重视长期随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Celiac disease may be associated with a modest but persistent increased long-term mortality risk. It is uncertain whether this risk has changed in the era of wider diagnosis rates, less severe clinical disease, and more widespread availability of gluten-free food. OBJECTIVE: To evaluate the association between celiac disease and mortality risk in a population-based cohort in Sweden. DESIGN, SETTING, AND PARTICIPANTS: All individuals in Sweden with celiac disease diagnosed between 1969 and 2017 were identified through the Epidemiology Strengthened by histoPathology Reports in Sweden (ESPRESSO) cohort. Participants (n = 49 829) were observed starting on the day of the biopsy. The final date of follow-up was December 31, 2017. EXPOSURES: Celiac disease was defined by the presence of small intestinal villus atrophy on histopathology specimens during the years 1969-2017 from Sweden's 28 pathology departments. Each individual was matched with as many as 5 control participants in the general population by age, sex, county, and calendar period. MAIN OUTCOMES AND MEASURES: The primary outcome was all-cause mortality, and the secondary outcome was cause-specific mortality. Patients with celiac disease were compared with controls using stratified Cox proportional modeling, stratifying by year of diagnosis. RESULTS: There were 49 829 patients with celiac disease, including 24% who were diagnosed between the years 2010 and 2017. The mean (SD) age at diagnosis was 32.2 (25.2) years and 62.4% were women. During a median follow-up time of 12.5 years, 13.2% (n = 6596) died. Compared with controls (n = 246 426), overall mortality was increased in those with celiac disease (9.7 vs 8.6 deaths per 1000 person-years; absolute difference, 1.2 per 1000 person-years; hazard ratio [HR], 1.21 [95% CI, 1.17-1.25]). The relative increase in mortality risk was present in all age groups and was greatest in those diagnosed in the age range of 18 to 39 years (1.9 vs 1.1 per 1000 person-years; HR, 1.69 [95% CI, 1.47-1.94]; P values for heterogeneity comparing 18-39 years with 40-59 years and with ≥60 years were both <.001). Individuals with celiac disease were at increased risk of death from cardiovascular disease (3.5 vs 3.4 per 1000 person-years; HR, 1.08 [95% CI, 1.02-1.13]), cancer (2.7 vs 2.2 per 1000 person-years; HR, 1.29 [95% CI, 1.22-1.36]), and respiratory disease (0.6 vs 0.5 per 1000 person-years; HR, 1.21 [95% CI, 1.08-1.37]). When compared with controls, the overall mortality risk was greatest in the first year after diagnosis (15.3 vs 6.5 per 1000 person-years; HR, 2.34 [95% CI, 2.14-2.55]) but persisted beyond 10 years after diagnosis (10.5 vs 10.1 per 1000 person-years; HR, 1.15 [95% CI, 1.10-1.20]). The mortality risk was likewise present for patients diagnosed during the years 2010-2017 (7.5 vs 5.5 per 1000 person-years; HR, 1.35 [95% CI, 1.21-1.51]). CONCLUSIONS AND RELEVANCE: In a Swedish population studied between 1969 and 2017, a diagnosis of celiac disease compared with the general population was associated with a small but statistically significant increased mortality risk.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Lebwohl B, Green PHR, Söderling J, et al. Association Between Celiac Disease and Mortality Risk in a Swedish Population. JAMA. 2020. PMID: 32259229. doi:10.1001/jama.2020.1943

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。